Katz MHG - Search Results

1

FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review.

Eshmuminov D, Aminjonov B, Palm RF, Malleo G, Schmocker RK, Abdallah R, Yoo C, Shaib WL, Schneider MA, Rangelova E, Choi YJ, Kim H, Rose JB, Patel S, Wilson GC, Maloney S, Timmermann L, Sahora K, Rössler F, Lopez-Lopez V, Boyer E, Maggino L, Malinka T, Park JY, Katz MHG, Prakash L, Ahmad SA, Helton S, Jang JY, Hoffe SE, Salvia R, Taieb J, He J, Clavien PA, Held U, Lehmann K. Eshmuminov D, et al. Among authors: katz mhg. Ann Surg Oncol. 2023 Jul;30(7):4417-4428. doi: 10.1245/s10434-023-13353-2. Epub 2023 Apr 5. Ann Surg Oncol. 2023. PMID: 37020094 Free PMC article. Review.

2

Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.

Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Katz MH, et al. Ann Surg Oncol. 2009 Apr;16(4):836-47. doi: 10.1245/s10434-008-0295-2. Epub 2009 Feb 5. Ann Surg Oncol. 2009. PMID: 19194760 Free PMC article.

3

Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.

Katz MH, Merchant NB, Brower S, Branda M, Posner MC, William Traverso L, Abrams RA, Picozzi VJ, Pisters PW; American College of Surgeons Oncology Group. Katz MH, et al. Ann Surg Oncol. 2011 Feb;18(2):337-44. doi: 10.1245/s10434-010-1282-y. Epub 2010 Sep 1. Ann Surg Oncol. 2011. PMID: 20811779 Free PMC article.

4

Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial.

Katz MH, Wolff R, Crane CH, Varadhachary G, Javle M, Lin E, Evans DB, Lee JE, Fleming JB, Pisters PW. Katz MH, et al. Ann Surg Oncol. 2011 Dec;18(13):3615-22. doi: 10.1245/s10434-011-1847-4. Epub 2011 Jun 24. Ann Surg Oncol. 2011. PMID: 21701927 Clinical Trial.

5

Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy.

Tzeng CW, Fleming JB, Lee JE, Xiao L, Pisters PW, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Fogelman DR, Crane CH, Balachandran A, Katz MH. Tzeng CW, et al. Ann Surg Oncol. 2012 Jun;19(6):2045-53. doi: 10.1245/s10434-011-2211-4. Epub 2012 Jan 19. Ann Surg Oncol. 2012. PMID: 22258816

6

Fear of cancer recurrence after curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumors.

Petzel MQ, Parker NH, Valentine AD, Simard S, Nogueras-Gonzalez GM, Lee JE, Pisters PW, Vauthey JN, Fleming JB, Katz MH. Petzel MQ, et al. Ann Surg Oncol. 2012 Dec;19(13):4078-84. doi: 10.1245/s10434-012-2566-1. Epub 2012 Aug 9. Ann Surg Oncol. 2012. PMID: 22875648

7

Borderline resectable pancreatic cancer: pushing the technical limits of surgery.

Katz MH, Ahmad S, Nelson H. Katz MH, et al. Bull Am Coll Surg. 2013 Jan;98(1):61-3. Bull Am Coll Surg. 2013. PMID: 23359915 No abstract available.

8

Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis.

Tzeng CW, Abbott DE, Cantor SB, Fleming JB, Lee JE, Pisters PW, Varadhachary GR, Abbruzzese JL, Wolff RA, Ahmad SA, Katz MH. Tzeng CW, et al. Ann Surg Oncol. 2013 Jul;20(7):2197-203. doi: 10.1245/s10434-013-2889-6. Epub 2013 Feb 14. Ann Surg Oncol. 2013. PMID: 23408126

9

Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design.

Katz MH, Marsh R, Herman JM, Shi Q, Collison E, Venook AP, Kindler HL, Alberts SR, Philip P, Lowy AM, Pisters PW, Posner MC, Berlin JD, Ahmad SA. Katz MH, et al. Ann Surg Oncol. 2013 Aug;20(8):2787-95. doi: 10.1245/s10434-013-2886-9. Epub 2013 Feb 23. Ann Surg Oncol. 2013. PMID: 23435609 Free PMC article. Review.

10

Treatment of borderline resectable pancreatic cancer.

Cooper AB, Tzeng CW, Katz MH. Cooper AB, et al. Curr Treat Options Oncol. 2013 Sep;14(3):293-310. doi: 10.1007/s11864-013-0244-6. Curr Treat Options Oncol. 2013. PMID: 23793524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

368 results

Search Page